Published in Nat Cell Biol on October 01, 2001
Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem (2009) 8.83
Ubiquitin-binding domains. Biochem J (2006) 5.32
A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J (2006) 4.95
Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature (2008) 4.76
Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol (2004) 3.98
Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J (2002) 3.12
Rad23 promotes the targeting of proteolytic substrates to the proteasome. Mol Cell Biol (2002) 3.01
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet (2002) 3.00
Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J (2011) 2.75
A ubiquitin-binding motif required for intramolecular monoubiquitylation, the CUE domain. EMBO J (2003) 2.73
Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome. Proc Natl Acad Sci U S A (2002) 2.63
RNA interference analysis of Legionella in Drosophila cells: exploitation of early secretory apparatus dynamics. PLoS Pathog (2006) 2.44
Targeting proteins for degradation. Nat Chem Biol (2009) 2.22
Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome. Mol Cell (2008) 2.12
A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein. Genes Dev (2003) 2.09
Sequestosome 1/p62--more than just a scaffold. FEBS Lett (2006) 2.07
A genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation. EMBO Rep (2004) 2.02
Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep (2003) 2.01
Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc Natl Acad Sci U S A (2002) 1.89
Multiple interactions of rad23 suggest a mechanism for ubiquitylated substrate delivery important in proteolysis. Mol Biol Cell (2004) 1.78
The Rsp5 ubiquitin ligase is coupled to and antagonized by the Ubp2 deubiquitinating enzyme. EMBO J (2005) 1.76
Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol Cell Biol (2005) 1.74
Affinity makes the difference: nonselective interaction of the UBA domain of Ubiquilin-1 with monomeric ubiquitin and polyubiquitin chains. J Mol Biol (2007) 1.71
Mechanism of Lys48-linked polyubiquitin chain recognition by the Mud1 UBA domain. EMBO J (2005) 1.70
Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol Cell Biol (2003) 1.68
Regulated protein turnover: snapshots of the proteasome in action. Nat Rev Mol Cell Biol (2014) 1.57
Structure of the s5a:k48-linked diubiquitin complex and its interactions with rpn13. Mol Cell (2009) 1.57
Structural determinants for the binding of ubiquitin-like domains to the proteasome. EMBO J (2003) 1.56
The 26 S proteasome: from basic mechanisms to drug targeting. J Biol Chem (2009) 1.55
Ubiquitin-associated domain of Mex67 synchronizes recruitment of the mRNA export machinery with transcription. Proc Natl Acad Sci U S A (2006) 1.54
Together, Rpn10 and Dsk2 can serve as a polyubiquitin chain-length sensor. Mol Cell (2009) 1.47
BAG-6 is essential for selective elimination of defective proteasomal substrates. J Cell Biol (2010) 1.46
The Png1-Rad23 complex regulates glycoprotein turnover. J Cell Biol (2006) 1.43
Localization of the proteasomal ubiquitin receptors Rpn10 and Rpn13 by electron cryomicroscopy. Proc Natl Acad Sci U S A (2012) 1.42
Involvement of the DNA repair protein hHR23 in p53 degradation. Mol Cell Biol (2003) 1.38
Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle. Mol Cell Biol (2005) 1.37
S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains. EMBO J (2009) 1.36
The comparative proteomics of ubiquitination in mouse. Genome Res (2003) 1.35
Human Fas-associated factor 1, interacting with ubiquitinated proteins and valosin-containing protein, is involved in the ubiquitin-proteasome pathway. Mol Cell Biol (2005) 1.33
The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol Biol Cell (2003) 1.32
In vitro analysis of Hrd1p-mediated retrotranslocation of its multispanning membrane substrate 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase. J Biol Chem (2009) 1.31
Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis (2010) 1.31
Structure of Rpn10 and its interactions with polyubiquitin chains and the proteasome subunit Rpn12. J Biol Chem (2010) 1.31
The DNA damage-inducible UbL-UbA protein Ddi1 participates in Mec1-mediated degradation of Ho endonuclease. Mol Cell Biol (2005) 1.30
Edd, the murine hyperplastic disc gene, is essential for yolk sac vascularization and chorioallantoic fusion. Mol Cell Biol (2004) 1.28
The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation. Biochem J (2006) 1.27
Targeted degradation of abscisic acid receptors is mediated by the ubiquitin ligase substrate adaptor DDA1 in Arabidopsis. Plant Cell (2014) 1.23
Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation. Cell Mol Life Sci (2009) 1.23
The Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimer. Mol Biol Cell (2006) 1.22
Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding. J Virol (2004) 1.17
Rpn1 and Rpn2 coordinate ubiquitin processing factors at proteasome. J Biol Chem (2012) 1.15
Rad23 stabilizes Rad4 from degradation by the Ub/proteasome pathway. Nucleic Acids Res (2004) 1.15
A conditional yeast E1 mutant blocks the ubiquitin-proteasome pathway and reveals a role for ubiquitin conjugates in targeting Rad23 to the proteasome. Mol Biol Cell (2007) 1.14
Protein targeting to ATP-dependent proteases. Curr Opin Struct Biol (2008) 1.14
Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2. J Biol Chem (2009) 1.13
A novel connexin43-interacting protein, CIP75, which belongs to the UbL-UBA protein family, regulates the turnover of connexin43. J Biol Chem (2007) 1.12
Identification of a functional docking site in the Rpn1 LRR domain for the UBA-UBL domain protein Ddi1. BMC Biol (2011) 1.12
Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein. J Biol Chem (2011) 1.11
Ubiquitin receptor proteins hHR23a and hPLIC2 interact. J Mol Biol (2006) 1.11
Defining how ubiquitin receptors hHR23a and S5a bind polyubiquitin. J Mol Biol (2007) 1.09
The ubiquilin gene family: evolutionary patterns and functional insights. BMC Evol Biol (2014) 1.08
A novel UBA and UBX domain protein that binds polyubiquitin and VCP and is a substrate for SAPKs. Biochem J (2004) 1.08
Mutations in the hydrophobic core of ubiquitin differentially affect its recognition by receptor proteins. J Mol Biol (2007) 1.07
UV-induced ubiquitylation of XPC complex, the UV-DDB-ubiquitin ligase complex, and DNA repair. J Mol Histol (2006) 1.07
Oxidative stress and programmed cell death in yeast. Front Oncol (2012) 1.06
Proteasomal ubiquitin receptor RPN-10 controls sex determination in Caenorhabditis elegans. Mol Biol Cell (2006) 1.04
A complex between peptide:N-glycanase and two proteasome-linked proteins suggests a mechanism for the degradation of misfolded glycoproteins. Proc Natl Acad Sci U S A (2004) 1.04
Internalized gap junctions are degraded by autophagy. Autophagy (2012) 1.04
Proteins and mechanisms regulating gap-junction assembly, internalization, and degradation. Physiology (Bethesda) (2013) 1.03
Proteotoxic stress increases nuclear localization of ataxin-3. Hum Mol Genet (2009) 1.02
Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets. Mol Biol Cell (2012) 1.02
Structure, dynamics and interactions of p47, a major adaptor of the AAA ATPase, p97. EMBO J (2004) 1.01
A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex. EMBO Rep (2012) 1.01
Yeast UBL-UBA proteins have partially redundant functions in cell cycle control. Cell Div (2006) 1.01
Degradation or maintenance: actions of the ubiquitin system on eukaryotic chromatin. Eukaryot Cell (2002) 1.00
Structure and interaction of ubiquitin-associated domain of human Fas-associated factor 1. Protein Sci (2009) 0.99
The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-coupled receptor endocytosis. Mol Biol Cell (2008) 0.99
E3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFalpha-induced JNK activation. Proc Natl Acad Sci U S A (2010) 0.99
Rad23 escapes degradation because it lacks a proteasome initiation region. Nat Commun (2011) 0.97
Dimerization of ubiquilin is dependent upon the central region of the protein: evidence that the monomer, but not the dimer, is involved in binding presenilins. Biochem J (2006) 0.97
Ubiquitin-independent proteasomal degradation of endoplasmic reticulum-localized connexin43 mediated by CIP75. J Biol Chem (2010) 0.96
Different domains of the UBL-UBA ubiquitin receptor, Ddi1/Vsm1, are involved in its multiple cellular roles. Mol Biol Cell (2008) 0.95
Yeast Pth2 is a UBL domain-binding protein that participates in the ubiquitin-proteasome pathway. EMBO J (2006) 0.95
A genome-wide synthetic dosage lethality screen reveals multiple pathways that require the functioning of ubiquitin-binding proteins Rad23 and Dsk2. BMC Biol (2009) 0.94
Dss1 is a 26S proteasome ubiquitin receptor. Mol Cell (2014) 0.93
UBQLN1 interacts with SPEM1 and participates in spermiogenesis. Mol Cell Endocrinol (2010) 0.93
Recognition and cleavage of related to ubiquitin 1 (Rub1) and Rub1-ubiquitin chains by components of the ubiquitin-proteasome system. Mol Cell Proteomics (2012) 0.93
DNA-damage-inducible 1 protein (Ddi1) contains an uncharacteristic ubiquitin-like domain that binds ubiquitin. Structure (2015) 0.92
Regulation of repair by the 26S proteasome. J Biomed Biotechnol (2002) 0.91
The Cdc48 ATPase modulates the interaction between two proteolytic factors Ufd2 and Rad23. Proc Natl Acad Sci U S A (2011) 0.91
Scythe regulates apoptosis through modulating ubiquitin-mediated proteolysis of the Xenopus elongation factor XEF1AO. Biochem J (2007) 0.90
Rad4 regulates protein turnover at a postubiquitylation step. Mol Biol Cell (2009) 0.90
Investigating the importance of proteasome-interaction for Rad23 function. Curr Genet (2002) 0.88
Components of the ubiquitin-proteasome pathway compete for surfaces on Rad23 family proteins. BMC Biochem (2008) 0.88
Defining an Embedded Code for Protein Ubiquitination. J Proteomics Bioinform (2009) 0.88
Structural insights into proteasome activation by the 19S regulatory particle. Biochemistry (2013) 0.87
Ubiquitinated proteome: ready for global? Mol Cell Proteomics (2011) 0.87
A new crystal form of Lys48-linked diubiquitin. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.87
Ubiquitin domain proteins in disease. BMC Biochem (2007) 0.86
A chaperone-assisted degradation pathway targets kinetochore proteins to ensure genome stability. PLoS Genet (2014) 0.86
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron (2000) 22.02
Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron (1996) 5.30
Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron (1996) 5.14
An evaluation of an alternative to long-stay hospital care for frail elderly patients: I. The model of care. Age Ageing (1991) 4.03
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 3.51
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1984) 3.24
A comparison of the reliability of self-reported drug use and sexual behaviors using computer-assisted versus face-to-face interviewing. AIDS Educ Prev (2000) 3.02
The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum (1995) 2.82
Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1989) 2.59
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J (1998) 2.43
A role for the Pkc1 MAP kinase pathway of Saccharomyces cerevisiae in bud emergence and identification of a putative upstream regulator. EMBO J (1997) 2.42
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37
Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother (1972) 2.35
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31
Shigella surveillance in the United States, 1975. J Infect Dis (1977) 2.31
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med (1998) 2.20
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
The role of continuous background infusions in patient-controlled epidural analgesia for labor and delivery. Anesth Analg (1994) 2.17
A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J Virol (1999) 2.12
Disablement following stroke. Disabil Rehabil (1999) 2.10
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist (2004) 1.97
Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) (2007) 1.97
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
Protein topology of presenilin 1. Neuron (1996) 1.94
The cell cycle genes cdc22+ and suc22+ of the fission yeast Schizosaccharomyces pombe encode the large and small subunits of ribonucleotide reductase. Mol Gen Genet (1993) 1.88
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Clathrin-dependent localization of alpha 1,3 mannosyltransferase to the Golgi complex of Saccharomyces cerevisiae. J Cell Biol (1994) 1.79
Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci (2000) 1.77
What proportion of patients refuse consent to data collection from their records for research purposes? Br J Gen Pract (2000) 1.74
A conditional lethal mutant in the fission yeast 26 S protease subunit mts3+ is defective in metaphase to anaphase transition. J Biol Chem (1996) 1.70
The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J Biol Chem (1995) 1.70
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Effects of transplantation on the primitive immunohematopoietic stem cell. J Exp Med (1990) 1.68
From BILAG to BLIPS--disease activity assessment in lupus past, present and future. Lupus (2000) 1.68
The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations. Genomics (1990) 1.66
Efficacy of breathing and coughing exercises in the prevention of pulmonary complications after coronary artery surgery. Chest (1994) 1.66
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
Associates of health status in patients with systemic lupus erythematosus. J Rheumatol (1999) 1.62
Localization of the 26S proteasome during mitosis and meiosis in fission yeast. EMBO J (1998) 1.61
Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol (2005) 1.61
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 1.60
Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials (1998) 1.59
Accelerated re-epithelialization in beta3-integrin-deficient- mice is associated with enhanced TGF-beta1 signaling. Nat Med (2005) 1.58
Numbers and functions of transplantable primitive immunohematopoietic stem cells. Effects of age. J Immunol (1989) 1.57
Trainable rule-based algorithm for the measurement of joint space width in digital radiographic images of the knee. Med Phys (2000) 1.52
Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends Genet (2000) 1.51
Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet Rec (2013) 1.51
Yield of colonoscopy in patients with nonacute rectal bleeding: a multicenter database study of 1766 patients. Am J Gastroenterol (2002) 1.50
Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimens. J Clin Virol (2000) 1.49
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum (1994) 1.48
A fruiting body tissue method for efficient Agrobacterium-mediated transformation of Agaricus bisporus. Appl Environ Microbiol (2000) 1.47
Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay. Br J Pharmacol (1980) 1.45
The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) (1999) 1.45
Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci (1996) 1.44
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J Infect Dis (1991) 1.43
Developments of computer-based estimation of pA2 values and associated analysis. J Pharmacol Exp Ther (1978) 1.43
Nanoscale design of snake skin for reptation locomotions via friction anisotropy. J Biomech (1999) 1.43
Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis (2005) 1.42
Validation of recombinant Sendai virus in a non-natural host model. Gene Ther (2010) 1.42
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A (2000) 1.42
Enhancement of bupivacaine cardiotoxicity with cardiac glycosides and beta-adrenergic blockers: a case report. Anesth Analg (1993) 1.41
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis (2007) 1.37
Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit. J Biol Chem (1997) 1.37
Genetic variation for total fitness in Drosophila melanogaster. Proc Biol Sci (1997) 1.37
Transversal and longitudinal images from the retina of the living eye using low coherence reflectometry. J Biomed Opt (1998) 1.36
Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified? Dis Colon Rectum (2007) 1.36
CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques. J Virol (1998) 1.36
Chromosome analysis before birth and its value in genetic counselling. Br Med J (1971) 1.35
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J Virol (2000) 1.30
Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. Br J Cancer (2010) 1.29
An evaluation of an alternative to long-stay hospital care for frail elderly patients: II. Costs and effectiveness. Age Ageing (1991) 1.28
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology (2008) 1.27
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res (2001) 1.26
Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res (1991) 1.26
"Tenosynovitis". J Hand Surg Br (1986) 1.25
Impaired functional capacity is associated with all-cause mortality after major elective intra-abdominal surgery. Br J Anaesth (2010) 1.25
Heterologous expression of biphenyl dioxygenase-encoding genes from a gram-positive broad-spectrum polychlorinated biphenyl degrader and characterization of chlorobiphenyl oxidation by the gene products. J Bacteriol (1997) 1.24
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome. Rheumatology (Oxford) (2004) 1.23
The new OPCS area classifications. Popul Trends (1995) 1.23
Effect of external pH perturbations on in vivo protein synthesis by the acidophilic bacterium Thiobacillus ferrooxidans. J Bacteriol (1991) 1.22
Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER). Lupus (2011) 1.21
Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J Biol Chem (1995) 1.20
Analysis of a gene encoding Rpn10 of the fission yeast proteasome reveals that the polyubiquitin-binding site of this subunit is essential when Rpn12/Mts3 activity is compromised. J Biol Chem (2000) 1.20
Is liver transplantation indicated for cholangiocarcinoma? Am J Surg (1993) 1.20
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheumatol (1999) 1.19
The organization and results of a pregnancy termination service in a National Health Service hospital. J Obstet Gynaecol Br Commonw (1974) 1.19
Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis (2005) 1.19
Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg (1993) 1.19
The latency-related gene of bovine herpesvirus 1 inhibits programmed cell death. J Virol (1999) 1.18